GGrantIndex
← Leaderboards

Daniel W Chan

Johns Hopkins University

$17,758,540
Attributed
$32,961,128
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.9M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$35,562,156 · 10

By mechanism

U24$28,834,200 · 4
U2C$4,303,809 · 4
U01$2,404,147 · 1
R13$20,000 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Resources

Research focus

ResourcesTechnologyProteomicsProteinsSuccessMalignant NeoplasmsBioinformaticsDiagnosticTranslationsScientistLaboratoriesSpecimenClinical ChemistryBaseMultidisciplinaryIndustryBiological MarkersCollaborationsMass Spectrum AnalysisValidationAssay DevelopmentClinical ResearchEarly Detection Research NetworkQuality Control

Grant awards (48)

Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$1,137,216
U24 · FY2025 · CA
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs$985,366
U2C · FY2025 · CA · contact PI
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$809,563
U01 · FY2025 · CA · contact PI
Admin Core$369,985
U2C · FY2025 · CA · contact PI
Biomarker Reference Laboratory$265,847
U2C · FY2025 · CA · contact PI
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$1,084,866
U24 · FY2024 · CA
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs$936,098
U2C · FY2024 · CA · contact PI
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$769,085
U01 · FY2024 · CA · contact PI
Admin Core$354,330
U2C · FY2024 · CA · contact PI
Biomarker Reference Laboratory$247,738
U2C · FY2024 · CA · contact PI
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$1,119,051
U24 · FY2023 · CA
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$982,438
U24 · FY2023 · CA
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$825,499
U01 · FY2023 · CA · contact PI
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs$679,564
U2C · FY2023 · CA · contact PI
Biomarker Reference Laboratory$237,151
U2C · FY2023 · CA · contact PI
Admin Core$63,687
U2C · FY2023 · CA · contact PI
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision$1,157,752
U24 · FY2022 · CA
Biomarker Reference Laboratory$164,043
U2C · FY2022 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$340,200
U24 · FY2021 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,061,100
U24 · FY2020 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$486,000
U24 · FY2020 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,029,264
U24 · FY2019 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$333,159
U24 · FY2019 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,061,100
U24 · FY2018 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$571,325
U24 · FY2018 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,059,750
U24 · FY2017 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$486,000
U24 · FY2017 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cance Research$1,307,657
U24 · FY2016 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,056,780
U24 · FY2016 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$648,000
U24 · FY2016 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,859,557
U24 · FY2015 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$126,997
U24 · FY2015 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,890,981
U24 · FY2014 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$367,325
U24 · FY2014 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,824,239
U24 · FY2013 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$362,415
U24 · FY2013 · CA · contact PI
Translational Proteomics: Biology, Technology and Clinical Advances$20,000
R13 · FY2013 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,875,068
U24 · FY2012 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$392,619
U24 · FY2012 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,962,728
U24 · FY2011 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$402,374
U24 · FY2011 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$418,200
U24 · FY2010 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$144,618
U24 · FY2010 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$434,723
U24 · FY2009 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$432,668
U24 · FY2008 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$430,315
U24 · FY2007 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$438,625
U24 · FY2006 · CA · contact PI
Clinical and Analytical Validation of Cancer Biomarkers$549,090
U24 · FY2005 · CA